cell and gene therapy

Boehringer and partners set sights on cystic fibrosis gene therapy. Deal builds on 17 years work in UK academic consortium. … plus technology transfer company Imperial Innovations, and cell and gene therapy drug delivery specialists Oxford BioMedica Jon … (본문 전체 8/6/2018 8:37 PM)

관련뉴스

  1. Cystic fibrosis therapy that improves cell function granted EU approval Vertex was granted marketing authorization for its cystic fibrosis therapy in a combination regimen … of a person with CF may result in proteins that don’t make it to the cell surface, where they are normally located, or in proteins at the cell … (본문 전체 11/7/2018 10:15 PM)...

  2. Discovery of new epithelial lung cell type may affect cystic fibrosis therapy Scientists have discovered a new type of cell in the human respiratory tract called the pulmonary ionocyte, and linked it to lung function decline in cystic fibrosis. Pulomonary ionocytes make up about one percent of the cells in the lung and are thought … (본문 전체 8/3/2018 9:20 PM)...

  3. New research has pointed to a cell replacement treatment for cystic fibrosis Cells that cause the debilitating and ultimately fatal cystic fibrosis could be successfully replaced with healthy ones, new research has found. University of Adelaide scientists have applied cell transplantation therapy, used in bone marrow transplants … (본문 전체 8/2/2018 5:23 PM)...

  4. Asymmetrex Proposes “Stemgene Therapy” to Emphasize the Importance of Tissue Stem Cells for Successful Gene Therapy James Sherley heads a biotechnology company that offers a technology-enabled service to the fields of stem cell research, stem cell regenerative medicine, and drug discovery. Asymmetrex offers the first-in-kind technology for specific counting of adult … Date : 2018-07-24T14:32:00.000Z Source : http://www.bio-medicine.org/biology-news-1/Asymmetrex-Proposes–u201CStemgene-Therapy-u201D-to-Emphasize-the-Importance-of-Tissue-Stem-Cells-for-Successful-Gene-Therapy-39224-1/...

  5. Cryoport Partners with World Courier to Provide Best-In-Class Logistics Platform for Global Cell and Gene Therapy Market Cryoport, Inc. (NASDAQ: CYRX, CYRXW) (“Company”), today announced that World Courier, a part of AmerisourceBergen, will integrate Cryoport’s full suite of temperature-controlled solutions into its global network. Integrated platform offers complete … Date : 2018-07-17T05:01:00.000Z Source : https://www.globalbankingandfinance.com/cryoport-partners-with-world-courier-to-provide-best-in-class-logistics-platform-for-global-cell-and-gene-therapy-market/...

  6. Out of prison, the ‘father of gene therapy’ faces a harsh reality: a tarnished legacy and an ankle monitor Gene therapy then, and now, involves slipping a healthy gene into millions of innocuous viruses, which carry the gene into the cells they infect. The girls in the historic experiment had ADA deficiency, which causes severe combined immunodeficiency … Date : 2018-07-23T08:53:00.000Z Source : https://www.statnews.com/2018/07/23/w-french-anderson-father-of-gene-therapy/...

  7. Extract Technology To Exhibit Cell Therapy Isolator At PDA Cell And Gene Therapy Conference The 2018 PDA Cell and Gene Therapy Conference (October 23-24) will provide a broad overview of current innovations with a focus on what it takes to successfully steward these therapies toward approval and beyond. The Conference will be an ideal forum for … (본문 전체 10/12/2018 5:07 PM)...

  8. Gene editing may enhance CAR T-cell therapy for hematologic malignancies Researchers at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis have used gene editing technology known as CRISPR to engineer human T cells to attack certain cancers. Results from studies conducted … Date : 2018-07-17T20:39:00.000Z Source : https://www.healio.com/hematology-oncology/leukemia/news/online/%7B36c82695-07c0-4de6-88a1-db5aba5043cf%7D/gene-editing-may-enhance-car-t-cell-therapy-for-hematologic-malignancies...

  9. GE Healthcare Life Sciences Opens Cell And Gene Therapy Asia Technology Center In Shanghai Building GE Healthcare’s first cell and gene therapy laboratory in Asia, the center aims to enable new developments and commercialization of precision medicine in Asia. To accelerate the clinical transformation and delivery of cellular and gene therapies … (본문 전체 9/1/2018 1:53 AM)...

  10. Stem cell therapy boost for cystic fibrosis treatment Thank you for subscribing to story notifications. The University of Adelaide research published in the journal Stem Cell Research and Therapy applies cell transplantation therapy, normally used in bone marrow transplants to treat immunodeficiency disorders. (본문 전체 8/2/2018 3:37 PM)...

  11. Cell Therapy Company and Chinese Firm Sign Marketing Deal In exchange for an upfront investment and milestone payments, RepliCel and YOFOTO will collaborate on the “development and commercialization in Greater China of RepliCel’s tendon regeneration cell therapy (RCT-01), skin rejuvenation cell therapy (RCS-01 … Date : 2018-07-17T05:36:00.000Z Source : http://menafn.com/1097168099/Cell-Therapy-Company-and-Chinese-Firm-Sign-Marketing-Deal...

  12. Gene Therapy for Sickle-Cell Diseases| a Drug Pipeline Analysis Report 2018| Technavio LONDON–(BUSINESS WIRE)–Technavio has announced their latest pipeline analysis report on gene therapy for sickle-cell diseases. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period … Date : 2018-07-25T22:44:00.000Z Source : https://www.businesswire.com/news/home/20180725005688/en/Gene-Therapy-Sickle-Cell-Diseases-Drug-Pipeline-Analysis...

  13. 9 Challenges Keeping Cell And Gene Therapy Executives Up At Night Despite recent progress in regenerative medicine, cell and gene therapy executives are still pioneering many new pathways as they shape science into never-before-realized medicinal applications. From innovation and growth come surmountable, yet challenging … Date : 2018-07-30T14:39:00.000Z Source : https://www.lifescienceleader.com/doc/challenges-keeping-cell-and-gene-therapy-executives-up-at-night-0001...

  14. Global Cancer Gene Therapy Market Opportunity Assessment|Key Players: Sibiono Genetech, Human Stem Cell Institute, Altor Bioscience Corporation, Amgen Global Cancer Gene Therapy to exceed USD 4 billion by 2024 as per a new research report. Robust research and development in the field of cancer gene therapy aimed at finding cure for rare genetic cancer will drive the market growth over forecast timeframe. (본문 전체 10/6/2018 6:26 PM)...

  15. Global Cell and Gene Therapy CROs Market, 2018-2030: Promising Treatment Options for a Myriad of Complex Clinical Conditions The “Cell and Gene Therapy CROs Market, 2018-2030” report has been added to ResearchAndMarkets.com’s offering. The Cell and Gene Therapy CROs Market, 2018-2030′ report features a comprehensive … (본문 전체 12/5/2018 11:58 PM)...

  16. Cell and Gene Therapy CROs Market, 2018-2030 – ResearchAndMarkets.com The “Cell and Gene Therapy CROs Market, 2018-2030” report has been added to ResearchAndMarkets.com’s offering. The Cell and Gene Therapy CROs Market, 2018-2030′ report features a comprehensive study on the current landscape of contract research service … (본문 전체 12/6/2018 1:25 AM)...

  17. Sangamo to buy TxCell, cell therapy tech in $84M deal Gene therapy biotech Sangamo Therapeutics is betting genetically modified immune cells can play as much of a role in treating immunological diseases as they have in certain blood cancers, announcing Monday plans to buy small French company TxCell and its … Date : 2018-07-23T16:00:00.000Z Source : https://www.biopharmadive.com/news/sangamo-buys-txcell-cell-therapy-tech-in-84m-deal/528368/...

  18. Stevenage Cell and Gene Therapy Catapult centre gets green light to make new cell and gene therapies New life-changing cell and gene therapies for use in health services around the world will be produced in Stevenage by innovative biotech firms as the Cell and Gene Therapy Catapult (CGT Catapult) is granted new licences. The licences, awarded by the … (본문 전체 9/12/2018 3:54 AM)...

  19. Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing NEW YORK, Sept. 10, 2018 /PRNewswire/ — Report Scope: The study scope includes clinical therapies using gene editing, gene therapy, genetically modified cell therapy (chimeric antigen receptor T-cells, or CAR T-cells) or RNA therapy platforms.Delivery … (본문 전체 9/10/2018 10:33 PM)...

  20. 4 Future Scenarios For Cell And Gene Therapy Adoption Cell and gene therapies are finally becoming a reality, with hundreds of clinical trials underway and some major therapeutic breakthroughs already reaching the market. In the past year alone, the FDA approved its first gene therapy, Spark’s Luxturna for … (본문 전체 8/9/2018 5:42 AM)...